Molecular Pathways: Targeting MALT1 Paracaspase Activity in LymphomaFONTAN, Lorena; MELNICK, Ari.Clinical cancer research (Print). 2013, Vol 19, Num 24, pp 6662-6668, issn 1078-0432, 7 p.Article

Histone deacetylases as therapeutic targets in hematologic malignanciesMELNICK, Ari; LICHT, Jonathan D.Current opinion in hematology. 2002, Vol 9, Num 4, pp 322-332, issn 1065-6251Article

Epigenetics and B-cell lymphomaSHAKNOVICH, Rita; MELNICK, Ari.Current opinion in hematology. 2011, Vol 18, Num 4, pp 293-299, issn 1065-6251, 7 p.Article

B-cell lymphoma 6 and the molecular pathogenesis of diffuse large B-cell lymphomaWEIMIN CI; POLO, Jose M; MELNICK, Ari et al.Current opinion in hematology. 2008, Vol 15, Num 4, pp 381-390, issn 1065-6251, 10 p.Article

The theoretical basis of transcriptional therapy of cancer : Can it be put into practice?MELNICK, Ari M; ADELSON, Kerin; LICHT, Jonathan D et al.Journal of clinical oncology. 2005, Vol 23, Num 17, pp 3957-3970, issn 0732-183X, 14 p.Article

Reversible disruption of BCL6 repression complexes by CD40 signaling in normal and malignant B cellsPOLO, Jose M; WEIMIN CI; LICHT, Jonathan D et al.Blood. 2008, Vol 112, Num 3, pp 644-651, issn 0006-4971, 8 p.Article

Molecular pathogenesis of acute promyelocytic leukaemia and APL variantsSIRULNIK, Andres; MELNICK, Ari; ZELENT, Arthur et al.Baillière's best practice & research. Clinical haematology. 2003, Vol 16, Num 3, pp 387-408, issn 1521-6926, 22 p.Article

Auranofin Induces Lethal Oxidative and Endoplasmic Reticulum Stress and Exerts Potent Preclinical Activity against Chronic Lymphocytic LeukemiaFISKUS, Warren; SABA, Nakhle; AUSTIN, Christopher P et al.Cancer research (Chicago, Ill.). 2014, Vol 74, Num 9, pp 2520-2532, issn 0008-5472, 13 p.Article

CD25 expression status improves prognostic risk classification in AML independent of established biomarkers: ECOG phase 3 trial, E1900GÖNEN, Mithat; SUN, Zhuoxin; MELNICK, Ari et al.Blood. 2012, Vol 120, Num 11, pp 2297-2306, issn 0006-4971, 10 p.Article

IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigeneticsSASAKI, Masato; KNOBBE, Christiane B; YOU-TEN, Annick et al.Nature (London). 2012, Vol 488, Num 7413, pp 656-659, issn 0028-0836, 4 p.Article

Promoter hypermethylation in MLL-r infant acute lymphoblastic leukemia: biology and therapeutic targetingSCHAFER, Eric; IRIZARRY, Rafael; NEGI, Sandeep et al.Blood. 2010, Vol 115, Num 23, pp 4798-4809, issn 0006-4971, 12 p.Article

LITAF, a BCL6 target gene, regulates autophagy in mature B-cell lymphomasBERTOLO, Cristina; ROA, Sergio; AMAR, Salomon et al.British journal of haematology. 2013, Vol 162, Num 5, pp 621-630, issn 0007-1048, 10 p.Article

Pre-B cell receptor-mediated activation of BCL6 induces pre-B cell quiescence through transcriptional repression of MYCNAHAR, Rahul; RAMEZANI-RAD, Parham; MÜSCHEN, Markus et al.Blood. 2011, Vol 118, Num 15, pp 4174-4178, issn 0006-4971, 5 p.Article

Outcome of Deferred Initial Therapy in Mantle-Cell LymphomaMARTIN, Peter; CHADBURN, Amy; MELNICK, Ari et al.Journal of clinical oncology. 2009, Vol 27, Num 8, pp 1209-1213, issn 0732-183X, 5 p.Article

SOX4 enables oncogenic survival signals in acute lymphoblastic leukemiaRAMEZANI-RAD, Parham; HUIMIN GENG; LEFEBVRE, Véronique et al.Blood. 2013, Vol 121, Num 1, pp 148-155, issn 0006-4971, 8 p.Article

BCL6 enables Ph⁺ acute lymphoblastic leukaemia cells to survive BCR―ABL1 kinase inhibitionDUY, Cihangir; HURTZ, Christian; PARK, Eugene et al.Nature (London). 2011, Vol 473, Num 7347, pp 384-388, issn 0028-0836, 5 p.Article

Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphomaLESHCHENKO, Violetta V; KUO, Pei-Yu; SUH, K. Stephen et al.Blood. 2010, Vol 116, Num 7, pp 1025-1034, issn 0006-4971, 10 p.Article

The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCLWEIMIN CI; POLO, Jose M; ELEMENTO, Olivier et al.Blood. 2009, Vol 113, Num 22, pp 5536-5548, issn 0006-4971, 13 p.Article

IDH mutation impairs histone demethylation and results in a block to cell differentiationCHAO LU; WARD, Patrick S; WELLEN, Kathryn E et al.Nature (London). 2012, Vol 483, Num 7390, pp 474-478, issn 0028-0836, 5 p.Article

Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesisBUSQUE, Lambert; PATEL, Jay P; HASSIMI, Maryam et al.Nature genetics. 2012, Vol 44, Num 11, pp 1179-1184, issn 1061-4036, 6 p.Article

The Leukemogenicity of AML1-ET0 Is Dependent on Site-Specific Lysine AcetylationLAN WANG; GURAL, Alexander; ASAI, Takashi et al.Science (Washington, D.C.). 2011, Vol 333, Num 6043, pp 765-769, issn 0036-8075, 5 p.Article

DNMT3B7, a Truncated DNMT3B Isoform Expressed in Human Tumors, Disrupts Embryonic Development and Accelerates LymphomagenesisSHAH, Mrinal Y; VASANTHAKUMAR, Aparna; LE BEAU, Michelle M et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 14, pp 5840-5850, issn 0008-5472, 11 p.Article

Translocations of the RARα gene in acute promyelocytic leukemiaZELENT, Arthur; GUIDEZ, Fabien; MELNICK, Ari et al.Oncogene (Basingstoke). 2001, Vol 20, Num 49, pp 7186-7203, issn 0950-9232Article

Prolonged Administration of Azacitidine With or Without Entinostat for Myelodysplastic Syndrome and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Results of the US Leukemia Intergroup Trial E1905PREBET, Thomas; ZHUOXIN SUN; PAIETTA, Elisabeth et al.Journal of clinical oncology. 2014, Vol 32, Num 12, pp 1242-1248, issn 0732-183X, 7 p.Article

Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemiaTIBURCIO RIBEIRO, Ana Flávia; PRATCORONA, Marta; VALK, Peter J. M et al.Blood. 2012, Vol 119, Num 24, pp 5824-5831, issn 0006-4971, 8 p.Article